IU1 (another USP14 inhibitor) restrains the activity of cancer-promoting macrophages by inhibiting fatty acid metabolism [236]; capzimin (an RPN11inhibitor) stabilizes the substrate and presents anti-proliferative effects on tumor cells [237]. Here, USP14 is linked to cancer.